Conclusion
We performed pharmaceutical care for patients with mild or moderate COVID-19 at Jianghan Fangcang hospital. A retrospective study was followed to evaluate the usefulness of Clinical pharmacists at Fangcang hospitals, which indicate that clinical pharmacist can effectively reduce and prevent drug-related, life-related and COVID-19-related problems for COVID-19 patients. This work may reduce the work pressure of first line medical staffs, provide possible work patterns for clinical pharmacist in other hospital and give more professional service for Fangcang hospital patients.
Acknowledgements: The research reported in this publication was supported by National Key R&D Program of China 2017YFC0909900. Yu Zhang and Yong Han contributed to the concept and design of this article, Dongyuan Wang and Yihui Liu helped for the data analysis and wrote this manuscript, Fang Zeng, Fang Cheng helped for the data collection. Chen Shi helped for the revision of the article.